One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-137245
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 3 |
Affiliation: Hôpital Lyon Sud, Imperial College Healthcare NHS Trust, Hammersmith Hospital, Monash University, Monash Health, Institut Bergonié, Epizyme (United States), Barwon Health, Geelong Hospital, Centre Hospitalier Universitaire de Lille, Beatson West of Scotland Cancer Centre, Peter MacCallum Cancer Centre, Memorial Sloan Kettering Cancer Center, Institut Gustave Roussy, McGill University, Jewish General Hospital, Université de Caen Normandie, University of Michigan–Ann Arbor, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust
Analyzing Efficacy Outcomes from the Phase 2 Study of Single-Agent Tazemetostat As Third-Line Therapy in Patients with Relapsed or Refractory Follicular Lymphoma to Identify Predictors of Response
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
